PATENT CLAIM ANALYSIS

Application Number: 15775990
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "338000"]

Abstract:
The present invention provides compounds of the formula below (I′): where R, and R1-R3 are as described herein, methods of treating patients for certain types of autoimmune diseases and cancer, and processes for preparing the compounds.

Claim (Index 28):
A pharmaceutical composition comprising a compound according to  claim 12  and a pharmaceutically acceptable carrier, diluent or excipient.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.26471
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15532937', '15874987', '13617035', '14420003', '15744641']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7463015658821341
- 35 USC 102 Novelty (BERT): 0.5240084929186756
- Combined Prediction Score: 0.7240722585857884
- Mean Citation Score: 301.05531600000006
- Max Citation Score: 307.48468
- Similarity Product: 212.75226518702743

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test